Occupational infections

Hunter’s Diseases of Occupations, Tenth edition

Volumn , Issue , 2010, Pages 729-749

  Heptonstall, Julia ^a   Cockcroft, Anne ^b  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b Autonomous University of Guerrero   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85084306408     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (158)

1. Health and Safety Commission. Biological agents ACOP (control of biological agents): Control of substances hazardous to health regulations. London: Health and Safety Executive, 1994.
2. Prüss-Ustün A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. American Journal of Industrial Medicine. 2005; 48: 482-90.
3. UK Benefits Agency. If you have an industrial disease: Industrial injuries disablement benefit (NI 2, August 1989, revised October 1991). London: HMSO, 1991.
4. West DJ. The risk of hepatitis B infection among health professionals in the United States: A review. American Journal of Medical Science. 1985; 287: 26-33.
5. Iserson KV, Criss EA. Hepatitis B prevalence in emergency physicians. Annals of Emergency Medicine. 1985; 14: 119-22.
6. McLean AA, Monahan GR, Finkelstein DM. Public health briefs: Prevalence of hepatitis B serologic markers in community hospital personnel. American Journal of Public Health. 1987; 77: 998-9.
7. Hadler SC, Doto IL, Maynard JE et al. Occupational risk of hepatitis B infection in hospital workers. Infection Control. 1985; 6: 24-31.
8. Reingold AL, Kane MA, Hightower AW. Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons. Journal of the American Medical Association. 1988; 259: 2558-60.
9. Petrosillo N, Puro V, Ippolito G and the Italian Study Group on Blood-Borne Occupational Risk in Dialysis. Prevalence of hepatitis C antibodies in health-care workers. Lancet. 1994; 344: 255-6.
10. Struve J, Aronsson B, Frenning B et al. Prevalence of hepatitis B virus markers and exposure to occupational risks likely to be associated with acquisition of hepatitis B virus among healthcare workers in Stockholm. Journal of Infection. 1992; 24: 147-56.
11. Panlilio AL, Shapiro CN, Schable CA et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Journal of the American College of Surgeons. 1995; 180: 16-24.
12. Polakoff S, Tillett HE. Acute viral hepatitis B: Laboratory reports 1975-9. British Medical Journal. 1982; 284: 1881-2.
13. Polakoff S. Acute viral hepatitis B: Laboratory reports 1980-4. British Medical Journal. 1986; 293: 37-8.
14. Collins M, Heptonstall J. Occupational acquisition of acute hepatitis B infection by healthcare workers in England and Wales, 1985-93. Communicable Disease Report. CDR Review. 1994; 4: R153-5.
15. Goldstein ST, Alter MJ, Williams IT et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs. Journal of Infectious Diseases. 2002; 185: 713-19.
16. Mahoney FJ, Stewart K, Hu H et al. Progress toward the elimination of hepatitis B virus transmission among healthcare workers in the United States. Archives of Internal Medicine. 1997; 157: 2601-5.
17. Lim DJ, Lingao A, Macasaet A. Sero-epidemiological study on hepatitis A and B virus infection among dentists in the Philippines. International Dental Journal. 1986; 36: 215-18.
18. Kashiwagi S, Hayashi J, Ikematsu H et al. Prevalence of immunologic markers of hepatitis A and B infection in hospital personnel in Miyazaki Prefecture, Japan. American Journal of Epidemiology. 1985; 122: 960-9.
19. Goldsmith RS, Zakaria S, Zakaria MS et al. Occupational exposure to hepatitis B virus in hospital personnel in Cairo, Egypt. Acta Tropica. 1989; 46: 283-90.
20. Hakre S, Reyes L, Bryan JP, Cruess D. Prevalence of hepatitis B virus among healthcare workers in Belize, Central America. American Journal of Tropical Medicine and Hygiene. 1995; 53: 118-22.
21. Belo AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East African Medical Journal. 2000; 77: 283-5.
22. Turner SB, Kunches LM, Gordon KF et al. Public health briefs. Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B virus among embalmers: A pilot seroprevalence study. American Journal of Public Health. 1989; 79: 1425-6.
23. Remis RS, Rossignol MA, Kane MA. Hepatitis B infection in a day school for mentally retarded students: Transmission from students to staff. American Journal of Public Health. 1987; 77: 1183-6.
24. Kunches LM, Craven DE, Werner BG, Jacobs LM. Hepatitis B exposure in emergency medical personnel: Prevalence of serologic markers and need for immunization. American Journal of Medicine. 1983; 75: 269-72.
25. Pepe PE, Hollinger FB, Troisi CL, Heiberg D. Viral hepatitis risk in urban emergency medical services personnel. Annals of Emergency Medicine. 1986; 15: 454-7.
26. Valenzuela TD, Hook EW, Copass MK, Corey L. Occupational exposure to hepatitis B in paramedics. Archives of Internal Medicine. 1985; 145: 1976-7.
27. Morgan-Capner P, Wallice PDB. Hepatitis B markers in ambulance personnel in Lancashire. Journal of the Society of Occupational Medicine. 1990; 40: 21-2.
28. Peterkin M, Crawford RJ. Hepatitis B vaccine for police forces? Lancet. 1986; ii: 1458-9.
29. Morgan-Capner P, Hudson P. Hepatitis B markers in Lancashire police officers. Epidemiology and Infection. 1988; 100: 145-51.
30. Welch J, Tilzey AJ, Bertrand J et al. Risk to Metropolitan police officers from exposure to hepatitis B. British Medical Journal. 1988; 297: 835-6.
31. Radvan GH, Hewson EG, Berenger S, Brookman DJ. The Newcastle hepatitis B outbreak: Observations on cause, management, and prevention. Medical Journal of Australia. 1986; 144: 461-4.
32. Crosse BA, Teale C, Lees EM. Hepatitis B markers in West Yorkshire firemen. Epidemiology and Infection. 1989; 103: 383-5.
33. Gerlich WH, Thomssen R. Outbreak of hepatitis B at a butcher’s shop. Deutsche Medizinische Wochenschrift. 1982; 107: 1627-30.
34. Mijch AM, Barnes R, Crowe SM et al. An outbreak of hepatitis B and D in butchers. Scandinavian Journal of Infectious Diseases. 1987; 19: 179-84.
35. Dembert ML, A-Shaffer R, Baugh NL et al. Epidemiology of viral hepatitis among US navy and marine personnel, 1984-85. American Journal of Public Health. 1987; 77: 1446-7.
36. Hyams KC, Palinkas LA, Burr RG. Viral hepatitis in the US navy, 1975-1984. American Journal of Epidemiology. 1989; 130: 319-26.
37. Siebke JC, Wessel N, Kvandal P, Lie T. The prevalence of hepatitis A and B in Norwegian merchant seamen: A serological study. Infection. 1989; 17: 77-80.
38. Cariani EA, Zonaro D, Primi E et al. Detection of HCV RNA and antibodies to HCV after needle stick injury. Lancet. 1991; 337: 850.
39. Abb J. Prevalence of hepatitis C virus antibodies in hospital personnel. International Journal of Medical Microbiology. 1991; 274: 543-7.
40. Jochen ABB. Occupationally acquired hepatitis C infection. Lancet. 1992; 339: 304.
41. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet. 1991; 338: 1539-2.
42. Frider B, Sookoian S, Castano G et al. Prevalence of hepatitis C in healthcare workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterologica Latinoamericana. 1994; 24: 71-5.
43. Thomas DL, Factor SH, Kelen GD et al. Viral hepatitis in health care personnel at the Johns Hopkins Hospital. Archives of Internal Medicine. 1993; 153: 1705-12.
44. Zuckerman J, Clewley G, Griffiths P, Cockcroft A. Prevalence of hepatitis C antibodies in clinical healthcare workers. Lancet. 1994; 343: 1618-20.
45. Neal KR, Dornan J, Irving WL. Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals: Who is at risk? British Medical Journal. 1997; 314: 179-80.
46. Thomas DL, Gruninger SE, Siew C et al. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. American Journal of Medicine. 1996; 100: 41-5.
47. Puro V, Petrosillo N, Ippolito G et al. and the Italian Study Group on Occupational Risk of Bloodborne Infections. Occupational hepatitis C virus infection in Italian healthcare workers. American Journal of Public Health. 1995; 85: 1272-5.
48. Shapiro CN, Tokars JI, Chamberland ME. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. Journal of Bone and Joint Surgery. American volume. 1996; 78: 1791-1800.
49. Tokars JI, Chamberland ME, Schable CA et al. A survey of occupational blood contact and HIV infection among orthopaedic surgeons. Journal of the American Medical Association. 1992; 268: 489-94.
50. Chamberland ME, Petersen LR, Munn VP et al. Human immunodeficiency virus infection among healthcare workers who donate blood. Annals of Internal Medicine. 1994; 121: 269-73.
51. Lowenfels AB, Wormser GP, Jain R. Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Archives of Surgery. 1989; 124: 1284-16.
52. Hussain SA, Latif ABA, Choudhary AAAA. Risk to surgeons: A survey of accidental injuries during operations. British Journal of Surgery. 1988; 75: 314-16.
53. Gerberding JL, Littell C, Tarkington A et al. Risk of exposure of surgical personnel to patients’ blood during surgery at San Francisco General Hospital. New England Journal of Medicine. 1990; 322: 1788-93.
54. Tokars J, Bell D, Marcus R et al. Percutaneous injuries during surgical procedures. Proceedings of the VII International Conference on AIDS, vol 2. Florence, Italy, 1991: 83.
55. Camilleri AE, Murray S, Imrie CW. Needlestick injuries in surgeons: What is the incidence? Journal of the Royal College of Surgeons of Edinburgh. 1991; 36: 317-8.
56. Williams S. Variables associated with the risk of blood exposures in operating theatres. MD thesis, University of London, 1997.
57. Brough SJ, Hunt TM, Barrie WW. Surgical glove perforations. British Journal of Surgery. 1988; 75: 317.
58. Camilleri AE, Murray S, Squair JL, Imrie CW. Epidemiology of sharps accidents in general surgery. Journal of the Royal College of Surgeons of Edinburgh. 1991; 36: 314-16.
59. Wright JG, McGeer AJ, Chyatte D, Ransohoff DF. Mechanisms of glove tears and sharp injuries among surgical personnel. Journal of the American Medical Association. 1991; 266: 1668-71.
60. Brearley S, Buist LJ. Blood splashes: An underestimated hazard to surgeons. British Medical Journal. 1989; 299: 1315.
61. Porteous MJ, Le F. Operating practices of and precautions taken by orthopaedic surgeons to avoid infection with HIV and hepatitis B virus during surgery. British Medical Journal. 1990; 301: 167-9.
62. Hinton AE, Herdman RC, Timms MS. Incidence and prevention of conjunctival contamination with blood during hazardous surgical procedures. Annals of the Royal College of Surgeons of England. 1991; 73: 239-42.
63. Richmond PW, McCabe M, Davies JP, Thomas DM. Perforation of gloves in an accident and emergency department. British Medical Journal. 1992; 304: 879-80.
64. Albertoni F, Ippolito G, Petrosillo N et al. Needlestick injury in hospital personnel: A multicenter survey from central Italy. Infection Control and Hospital Epidemiology. 1992; 13: 540-4.
65. Collins CH, Kennedy DA. Microbiological hazards of occupational needlestick and ‘sharps’ injuries. Journal of Applied Microbiology. 1987; 62: 385-402.
66. Metler R, Ciesielski C, Ward J, Marcus R. HIV seroconversions in clinical laboratory workers following occupational exposure, United States. VIIIth International Conference on AIDS, Amsterdam. July 1992: PoC 4147.
67. Beck-Sague CM, Jarvis WR, Fruehling JA et al. Universal precautions and mortuary practitioners: Influence on practices and risk of occupationally acquired infection. Journal of Occupational Medicine. 1991; 33: 874-8.
68. Astbury C, Baxter PJ. Infection risks in hospital staff from blood: Hazardous injury rates and acceptance of hepatitis B immunization. Journal of the Society of Occupational Medicine. 1990; 40: 92-3.
69. McGeer A, Sinor AE, Low DE. Epidemiology of needlestick injuries in house officers. Journal of Infectious Diseases. 1990; 162: 961-4.
70. Williams S, Gooch C, Cockcroft A. Hepatitis B immunisation and blood exposure incidents amongst operating department staff. British Journal of Surgery. 1993; 80: 714-16.
71. Hoofnagle JH, Seeff LB, Buskell Bales Z et al. Veterans Administration Study Group. Passive-active immunity from hepatitis B immunoglobulin. Re-analysis ofa Veterans Administration Cooperative Study of needle-stick hepatitis. Annals of Internal Medicine. 1979; 91: 813-18.
72. Grady GF, Lee VA, Prince AM et al. Hepatitis B immune globulin for accidental exposures among medical personnel: Final report of a multicenter controlled trial. Journal of Infectious Diseases. 1978; 138: 625-38.
73. Werner BA, Grady GF. Accidental hepatitis B surface antigen positive inoculations. Annals of Internal Medicine. 1982; 97: 367-9.
74. Reger A, Schiff ER. Clinical features of hepatitis. In: Thomas HC, Lemon SM, Zuckerman AJ (eds). Viral hepatitis, 3rd edn. Oxford: Blackwell Publishing, 2005: 33-49.
75. Kiyosawa K, Sodeyama T, Tanaka E et al. Hepatitis C in hospital employees with needlestick injuries. Annals of Internal Medicine. 1991; 115: 367-9.
76. Mitsui T, Iwano K, Masuko K et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology. 1992; 16: 1109-14.
77. Puro V, Petrosillo N, Ippolito G and the Italian Study Group on Occupational Risk of HIV and other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposure in healthcare workers. American Journal of Infection Control. 1995; 23: 273-7.
78. Hamid SS, Farooqui B, Rizvi Q et al. Risk of transmission and features of hepatitis C after needle stick injuries. Infection Control and Hospital Epidemiology. 1999; 20: 63-4.
79. Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clinical Microbiology Reviews. 2003; 16: 546-68.
80. Ippolito G, Puro V, Heptonstall J et al. Occupational human immunodeficiency virus infection in health careworkers: Worldwide cases through September 1997. Clinical Infectious Diseases. 1999; 28: 365-83.
81. UK Health Protection Agency Centre for Infections. Occupational transmission of HIV: Summary of published reports. March 2005 edition; data to December 2002. Last accessed June 19, 2009. Available from: www.hpa.org.uk/infections/topics_az/bbv/bbmenu.htm.
82. Cardo DM, Culver DH, Ciesielski CA et al. A case-control study of HIV seroconversion in healthcare workers after percutaneous exposure. New England Journal of Medicine. 1997; 337: 1485-90.
83. Yazdanpanah Y, De Carli G, Migueres B et al. Risk factors for hepatitis C virus transmission to healthcare workers after occupational exposure: A European case-control study. Clinical Infectious Diseases. 2005; 41: 1423-30.
84. Do AN, Ciesielski CA, Metler RP et al. Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States. Infection Control and Hospital Epidemiology. 2003; 24: 86-96.
85. Jagger J. Caring for healthcare workers: A global perspective. Infection Control and Hospital Epidemiology. 2007; 28: 1-4.
86. Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff. Communicable Disease Report. 1991; 1: R81-R85.
87. The Incident Investigation Teams and others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. New England Journal of Medicine. 1997; 336: 178-84.
88. Esteban JI, Gomez J, Martell M et al. Transmission of hepatitis C virus by a cardiac surgeon. New England Journal of Medicine. 1996; 334: 555-60.
89. Duckworth GJ, Heptonstall J, Aitken C for the Incident Control Team and others. Transmission of hepatitis C virus from a surgeon to a patient. Communicable Disease and Public Health. 1999; 2: 188-92.
90. Ross RS, Viazov S, Roggendorf M. Phylogenic analysis indicates transmission of hepatitis C virus from an infected orthopaedic surgeon to a patient. Journal of Medical Virology. 2002; 66: 461-7.
91. Ross RS, Viazov S, Thormahlen M et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: Results of a 7-year retrospective investigation. Archives of Internal Medicine. 2002; 162: 805-10.
92. Department of Health. Implementing getting ahead of the curve: Action on bloodborne viruses. Hepatitis C-infected healthcare workers. London: Department of Health, 2002.
93. Ciesielski C, Marianos D, Ou C-Y et al. Transmission of human immunodeficiency virus in a dental practice. Annals of Internal Medicine. 1992; 116: 798-805.
94. Lot F, Seguier JC, Fegueux S et al. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Annals of Internal Medicine. 1999; 130: 1-6.
95. Bosch X. Second case of doctor-to-patient HIV transmission. Lancet Infectious Diseases. 2003; 3: 261.
96. Department of Health. Hepatitis B infected healthcare workers. Guidance on implementation of Health Service Circular 2000/020. London: Department of Health, 2000.
97. Department of Health. Hepatitis B infected healthcare workers and antiviral therapy. London: Department of Health, 2007.
98. Department of Health. Health clearance for tuberculosis, hepatitis B, hepatitis C, and HIV: New healthcare workers. London: Department of Health, 2007.
99. Department of Health. HIV infected healthcare workers: Guidance on management and patient notification. London: Department of Health, 2005.
100. The Medical Schools Council, the Council of Heads and Deans of Dental Schools, Association of UK University Hospitals, and the Higher Education Occupational Physicians Group. Medical and dental students: Health clearance for hepatitis B, hepatitis C, HIV and tuberculosis, February 2008. Last accessed June 22, 2009. Available from: www.chms.ac.uk/documents/BBVsGuidance Feb2008_000.pdf.
101. Cockroft A, Griffiths P. Acquired immune deficiency syndrome (AIDS). In: Cox RAF, Edwards FC, Palmer K (eds). Fitness for work, the medical aspects, 3rd edn. Oxford: Oxford University Press, 2000: 463-79.
102. UK Health Departments. Guidance for Clinical Healthcare workers: Protection against infection with blood-borne viruses. Recommendations of the Expert Advisory Group on AIDS and the Advisory Group on Hepatitis. London: UK Health Departments, 1998.
103. Lamontagne F, Abiteboul D, Lolom I et al. Role of safetyengineered devices in preventing needlestick injuries in 32 French hospitals. Infection Control and Hospital Epidemiology. 2007; 28: 18-23.
104. Azar-Cavanagh M, Burdt P, Green-McKenzie J. Effect of the introduction of an engineered sharps injury prevention device on the percutaneous injury rate in healthcare workers. Infection Control and Hospital Epidemiology. 2007; 28: 165-70.
105. Valls V, Lozano MS, Yaʼnez R et al. Use of safety devices and the prevention of percutaneous injuries among healthcare workers. Infection Control and Hospital Epidemiology. 2007; 28: 1352-60.
106. Department of Health. The Health and Social Care Act 2008. Code of practice for the NHS on the prevention and control of health care associated infection and related guidance. Department of Health, London, United Kingdom, January 2009. Last accessed June 23, 2009. Available from: www.dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/DH_093762.
107. Boot HJ, van der Waaij LA, Schirm J et al. Acute hepatitis B in a health care worker: A case report of genuine vaccine failure. Journal of Hepatology. 2009; 50: 426-31.
108. Halpern SD, Asch DA, Shaked A et al. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons. Annals of Surgery. 2006; 244: 305-9.
109. Ramsey ME. Guidance on the investigation and management of occupational exposure to hepatitis C. Communicable Disease and Public Health. 1999; 2: 258-62. Last accessed May 29, 2009. Available from: www.phls.co.uk/topics_az/hepatitis_c/HepCguidelines.pdf.
110. Department of Health. HIV post-exposure prophylaxis: Guidance from the UK Chief Medical Officers’ Expert Advisory Group on AIDS. September 2008. London: Department of Health, 2008. Last accessed June 24, 2009. Available from: www.dh.gov.uk/en/publications andstatistics/publications/publicationspolicyandguidance/DH_088185.
111. Centers for Disease Control and Prevention. Updated US public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Reports. 2005; 54: RR-9.
112. Young T, Ahrens FJ, Kennedy GE et al. Antiretroviral postexposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Systematic Reviews. 2007; (1): CD002835.
113. Worthington MG, Ross JJ, Bergeron EK. Post traumatic stress disorder after occupational HIV exposure: Two cases and a literature review. Infection Control and Hospital Epidemiology. 2006; 27: 215-17.
114. Briese T, Paweska JT, McMullan LK et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathogens. 2009; last accessed June 24, 2009. Available from: www.plospathogens.org/article/info: doi/10.1371/journal.ppat.1000455. PMID: 19478873.
115. Advisory Committee on Dangerous Pathogens. Management and control of viral haemorrhagic fevers. London: HMSO, 1996.
116. Towner JS, Sealy TK, Khristova ML et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathogens. 2008; Last accessed June 24, 2009. Available from: www.plospathogens.org/article/info: doi/10.1371/journal.ppat.1000212.
117. Peters CJ. Marburg and Ebola-arming ourselves against the deadly filoviruses. New England Journal of Medicine. 2005; 352: 2571-3.
118. World Health Organization. Ebola Reston found in domestic pigs in the Philippines. Available from: www. wpro.who.int/health_topics/ebola_reston/EbolaReston_ FAQ.htm.
119. Baron RC, McCormick JB, Zubeir OA. Ebola virus dissemination in southern Sudan: Hospital dissemination and intrafamilial spread. Bulletin of the World Health Organization. 1983; 61: 997.
120. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Based on data as of 31 December 2003. Last accessed June 17, 2009. Available from: www.who.int/csr/sars/country/table2004_04_21/en/index.html.
121. Lim PL, Kurup A, Gopalakrishna G. Laboratory-acquired severe acute respiratory syndrome. New England Journal of Medicine. 2004; 350: 1740-5.
122. World Health Organization. Severe acute respiratory syndrome (SARS) in Taiwan, China. December 17, 2003. Last accessed May 23, 2006. Available from: www.who.int/csr/don/2003_12_17/en/index.html.
123. Tsang K, Ho P, Ooi G et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine. 2003; 348: 1977-85.
124. Svoboda T, Henry B, Shulman L et al. Public health measures to control the spread of severe acute respiratory syndrome during the outbreak in Toronto. New England Journal of Medicine. 2004; 350: 2352-61.
125. Shigayeva A, Green K, Raboud JM et al. for the SARS Hospital Investigation Team. Factors associated with critical-care healthcare workers’ adherence to recommended barrier precautions during the Toronto severe acute respiratory syndrome outbreak. Infection Control and Hospital Epidemiology. 2007; 28: 1275-83.
126. Ofner-Agostini M, Gravel D, McDonald LC et al. Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: A case series. Infection Control and Hospital Epidemiology. 2006; 27: 473-8.
127. Centers for Disease Control and Prevention. Respiratory hygiene/cough etiquette in healthcare settings. Last accessed May 23, 2009. Available from: www.cdc.gov/flu/professionals/infectioncontrol/resphygiene.htm.
128. World Health Organization. Infection prevention and control of epidemic-and pandemic-prone acute respiratory diseases in health care. WHO interim guidelines, June 2007. WHO/CDS/EPR/2007.6. Available from: www.who. int/csr/resources/publications/csrpublications/en/index7. html.
129. Department of Health. Pandemic influenza: Guidance for infection control in hospitals and primary care settings. November 2007. London: Department of Health, 2007.
130. Wang L-F, Shi Z, Zhang S et al. Review of bats and SARS. Emerging Infectious Diseases. 2006; 12: 1834-40. Last accessed June 24, 2009. Available from: www.cdc.gov/ncidod/EID/vol12no12/06-0401.htm.
131. Department of Health. Chickenpox (varicella) immunisation for healthcare workers PL/CMO/2003/8, PL/CNO/2003/9, PL/CDO/2003/1, PL/CPHO/2003/6. London: Department of Health. December 4, 2003.
132. Department of Health. Immunisation against infectious disease, 2006 edition. London: Department of Health, 2006. Available from: www.dh.gov.uk/en/Publichealth/Healthprotection/Immunisation/Greenbook/DH_4097254.
133. Geberding JL, Bryant-LeBlanc CE, Nelson K et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to healthcare workers exposed to patients with AIDS and AIDS-related conditions. Journal of Infectious Diseases. 1987; 156: 1-8.
134. Pillay D, Patou G, Hurt S et al. Parvovirus B19 outbreak in a children’s ward. Lancet. 1992; 339: 107-9.
135. Rosato FE, Rosato EF, Plotkin SA. Herpetic paronychia -An occupational hazard of medical personnel. New England Journal of Medicine. 1970; 283: 804-5.
136. Meredith S, Watson JM, Citron KM et al. Are healthcare workers in England and Wales at increased risk of tuberculosis? British Medical Journal. 1996; 313: 522-5.
137. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of practice, 2000. Thorax. 2000; 55: 887-901.
138. Beck-Sagu C, Dooley SW, Hutton MD et al. Outbreak of multidrug-resistant Mycobacterium tuberculosis infections in a hospital: Transmission to patients with HIV infection and staff. Journal of the American Medical Association. 1992; 268: 1280-6.
139. Pearson ML, Jereb JA, Frieden TR et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: A risk to patients and healthcare workers. Annals of Internal Medicine. 1992; 117: 257-8.
140. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Morbidity and Mortality Weekly Reports. 2005; 54: 1-141.
141. The Interdepartmental Working Group on Tuberculosis. The prevention and control of tuberculosis in the United Kingdom: UK guidance on the prevention and control of transmission of 1. HIV-related tuberculosis 2. Drugresistant, including multiple drug-resistant, tuberculosis. Department of Health, The Scottish Office, The Welsh Office, September 1998.
142. National Institute for Health and Clinical Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control, 2006. Last accessed June 24, 2009. Available from: www.nice. org.uk/page.aspx?o_CG033andc_infections.
143. Barrett NJ, Morse DL. The resurgence of scabies. Communicable Disease Report. CDR Review. 1993; 3: R32-34.
144. Gemmell CG, Edwards DI, Adam P et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. Journal of Antimicrobial Chemotherapy. 2006; 57: 589-608.
145. Coia E, Duckworth GJ, Edwards DI et al. Guidelines for the control and prevention of methicillin resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection. 2006; 66 (Suppl. 1): 1-44.
146. Holmes GP, Hilliard KJ, Kloutz KC et al. B virus (Herpes virus simiae) infection in humans: Epidemiologic investigations of a cluster. Annals of Internal Medicine. 1990; 112: 833-9.
147. Holmes GP, Chapman LE, Stewart JA et al. Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clinical Infectious Diseases. 1995; 20: 421-39.
148. Freifeld AG, Hilliard J, Southers J et al. A controlled seroprevalence survey or primate handlers for evidence of asymptomatic herpes B virus infection. Journal of Infectious Diseases. 1995; 171: 1031-4.
149. Centers for Disease Control and Prevention. Laboratoryacquired vaccinia exposures and infections -USA 2005-2007. Morbidity and Mortality Weekly Report. 2008; 57: 401-4.
150. Croft AMJ, Clayton TC, Gould MJ. Side effects of mefloquine prophylaxis for malaria: An independent randomised controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1997; 91: 199-203.
151. Advisory Committee on Malaria Prevention in UK Travellers (ACMP). Guidelines for malaria prevention in travellers from the United Kingdom 2007. London: Health Protection Agency, 2007.
152. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990; 84 (Suppl. 2): 1-65.
153. Lalloo DG, Shingadia D, Pasvol G et al. (on behalf of the HPA Advisory Committee on Malaria Prevention in UK Travellers). UK malaria treatment guidelines. Journal of Infection. 2007; 54: 111-21.
154. Knight R. Amoebiasis. In: Weatherall DJ, Ledingham JE, Warrel DA (eds). Oxford textbook of medicine, 3rd edn. Oxford: Oxford University Press, 1996: 825-35.
155. Chriske HW, Abdo R, Richrath R, Braumann S. Risk of hepatitis A infection among sewage workers. Arbeitsmedizin, Sozialmedizin, Präventivmedizin. 1990; 25: 285-7.
156. Skinhoj P, Hollinger FB, Hovind-Hougen K et al. Infectious liver diseases in three groups of Copenhagen workers: Correlation of hepatitis A infection to sewage exposure. Archives of Environmental Health. 1981; 36: 139-43.
157. Brugha R, Heptonstall J, Farrington P et al. Risk of hepatitis A infection in sewage workers. Occupational and Environmental Medicine. 1998; 55: 567-9.
158. Baxter PJ, Brazier AM, Young SEJ. Is smallpox a hazard in church crypts. British Journal of Industrial Medicine. 1998; 45: 359-60.